Neurocognitive complications are the most common sequelae of HIV infection
if the full spectrum of HIV disease-from initial seroconversion to death fr
om advanced AIDS-is considered. Though resembling subcortical neurological
disorders from a neuropsychological standpoint the presentation is variable
, and almost any pattern can be seen. Although neuropsychological impairmen
t is often subtle, it can affect day-to-day life and is associated with ear
lier mortality. It is not clear if milder forms of neurocognitive disturban
ce necessarily presage advanced dementia, and current data suggest a two-fa
ctor model: a subacute relapsing-remitting condition that can occur at any
stage of HIV disease and a progressive, more fulminant dementia. The pathol
ogical substrates of these conditions are not well characterized, although
recent data support the notion that synaptodendritic damage underlies the n
europsychological impairment, and may precede the neuronal loss and other p
athological features more characteristic of HN encephalitis. Some reversibi
lity of neurocognitive disturbance has been reported with zidovudine therap
y, though the data are not consistent. New regimens involving protease inhi
bitors need to be evaluated in terms of benefit to the central nervous syst
em because many drugs of this class do not penetrate the blood-brain barrie
r efficiently Finally, studies utilizing experimental treatments that may a
ffect the putative mechanisms of neural injury are in progress.